Aberrant expression of STYK1 and E-cadherin confer a poor prognosis for pancreatic cancer patients

Previous studies showed that aberrant Serine/threonine/tyrosine kinase 1 (STYK1, also known as NOK) or/and E-cadherin were involved in the progression of some types of human cancers. However, whether they contributed to the development of pancreatic cancer was unknown. Here, we investigated the prog...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Oncotarget
Asıl Yazarlar: Chen, Luguang, Ma, Chao, Bian, Yun, Shao, Chengwei, Wang, Tiegong, Li, Jing, Chong, Xiaodan, Su, Li, Lu, Jianping
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Impact Journals LLC 2017
Konular:
Research Paper
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5762325/
https://ncbi.nlm.nih.gov/pubmed/29340057
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.22794
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller